September 24, 2015, Montpellier, France – MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, is proud to announce that it will highlight its ROSA™ robotic surgery system at the 2015 Congress of Neurological Surgeons (CNS) Annual Meeting, held in New Orleans (USA) from September 28 to 30, 2015.
The CNS Annual Meeting is a premier forum gathering around 3,000 specialists in the field of neurosurgery and featuring the most cutting-edge procedures, approaches, and technologies in the field. Medtech will be exhibiting two ROSA™ robotic surgery systems at its booth (#417) for hands-on demonstrations of minimally-invasive brain and spine surgical procedures.
Founded in 2002 by Bertin NAHUM and based near Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.
In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada.
In 2013 Medtech received the « European Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan.
In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic-assistive device for minimally invasive surgery of the spine.
In October 2014, MEDTECH won the « Révélation » prize in the Mediterranean Deloitte Technology Fast 50 Awards.
Chief Financial Officer
Tel:+33 (0)4 67 10 77 40
Tel:+33 (0)1 53 67 36 77
|Alexandra Prisa (EU)
Tel.:+33(0)1 53 67 36 90
|Joanna Zimmerman (US)
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués
Full and original press release in PDF:
Si le fichier PDF ne s'affiche pas ou pour le télécharger, cliquez ici.
Pour consulter le fichier PDF en intégralité, cliquez ici.
|MEDTECH||Euronext Paris||50.00 (c)||0.00%||0|